Journals / Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi / 2016 / Cilt: 5 - Sayı: 3

GLYCEMIC CONTROL AND AFFECTING FACTORS IN PATIENTS WITH TYPE 2 DIABETES: THE ROLE OF DEPRESSION

TİP 2 DİYABETLİ HASTALARDA GLİSEMİK KONTROL DURUMU VE ETKİLEYEN ETMENLER: DEPRESYONUN ROLÜ

Pages
70–79
Publication Date
2016-07-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, quality monitoring of diabetic patients should include preventive mental health care.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, it was aimed to determine glycemic control and the effects of depression and some sociodemographic and clinical factors on glycemic control in outpatients with Type 2 Diabetes.
📊
Key Findings & Data:This cross-sectional study was conducted with 279 outpatients followed in the internal diseases department of a public hospital between January 2015 and March 2015.
💡
Conclusion & Impact:Therefore, quality monitoring of diabetic patients should include preventive mental health care.
🔬Design:Modeling & Simulation
📍Scope:2015 Verileri
⚙️Variables:Tip 2 Diyabet · Glisemik Kontrol · Depresyon

Abstract

In this study, it was aimed to determine glycemic control and the effects of depression and some sociodemographic and clinical factors on glycemic control in outpatients with Type 2 Diabetes. This cross-sectional study was conducted with 279 outpatients followed in the internal diseases department of a public hospital between January 2015 and March 2015. The data were collected using the Personal Information Form and Beck Depression Scale. Descriptive statistics, chi-square test, Fisher’s exact test, and logistics regression analysis were used to analyze the data. Glycemic control was achieved in 27.2% of the respondents. According to the logistic regression model, glycemic control was determined to be 2.14 times higher in the patients in the 65 and over age group, 1.45 times higher in those whose Body Mass Index was normal and 1.67 times higher in those having no depression than their counterparts. The results of the study revealed that glycemic control was achieved in one out of four patients, BMI and depression levels were determined to be modifiable risk factors affecting glycemic control. Therefore, quality monitoring of diabetic patients should include preventive mental health care.

Özet

Araştırmada ayaktan tedavi edilen tip 2 diyabetli hastalarda glisemik kontrol durumunun saptanması, depresyonun ve bazı sosyodemografik, klinik özelliklerin glisemik kontrol üzerine etkisinin belirlenmesi amaçlanmıştır. Kesitsel tipteki araştırma Ocak-Mart 2015 tarihleri arasında bir devlet hastanesi dahiliye polikliniğinde ayaktan tedavi edilen 279 hasta ile yürütülmüştür. Araştırmanın verileri Kişisel Bilgi Formu ve Beck Depresyon Ölçeği ile toplanmıştır. Veri analizinde tanımlayıcı istatistikler, ki kare, Fisher’in kesin testi ve lojistik regresyon analizi kullanılmıştır. Araştırma grubunun %27,2’sinde glisemik kontrolün sağlandığı belirlenmiştir. Lojistik regresyon modeline göre glisemik kontrolün 65 ve üzeri yaş grubunda 2,14 kat, normal Beden Kütle İndeksi’ne sahip olanlarda 1,45 kat, depresyon saptanmayanlarda 1,67 kat yüksek olduğu belirlenmiştir. Araştırmada yaklaşık her dört hastadan birinde glisemik kontrolün sağlandığı, BKİ ve depresyon düzeyinin glisemik kontrolü etkileyen değiştirilebilir birer risk faktörü olduğu belirlenmiştir.Bu doğrultuda koruyucu ruh sağlığı hizmetlerini içerecek şekilde diyabetlilerin nitelikli takibi sağlanmalıdır.

🔖

Cite This Article

AVCI, D., SELÇUK, K. T. (2016). GLYCEMIC CONTROL AND AFFECTING FACTORS IN PATIENTS WITH TYPE 2 DIABETES: THE ROLE OF DEPRESSION. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 5 - Sayı: 3, 70–79. https://ajindex.com/articles/668714

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care 2015; 38:1-93
  2. Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 2002; 25:1551-1556
  3. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013; 28:169-180
  4. Çıtıl R, Öztürk Y, Günay O. Kayseri il merkezinde bir sağlık ocağına başvuran diyabetik hastalarda metabolik kontrol durumu ve eşlik eden faktörler. Erciyes Tıp Dergisi 2010; 32:111-122
  5. Wee HL, Ho HK, Li SC. Public awareness of diabetes mellitus in Singapore Singapore Med J 2002; 43:128-134
  6. Buijsse B, Simmons RK, Griffin SJ, Schulze MB. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 2011; 33:46-62
  7. Tekeşin A, Doğan B, Yağız O, Polat H. Tip 2 diyabetli hastalarda serebrovasküler hastalık ile HBA1C arasındaki korelasyon. Istanbul Med J 2014; 15:40-42
  8. Guidelines for the prevention, management and care of diabetes mellitus. Available at: http://applications.emro.who.int/dsaf/dsa664.pdf. (Accessed January 12, 1016)
  9. Tanrıverdi MH, Çelepkolu T, Aslanhan H. Diyabet ve birinci basamak sağlık hizmetleri. J Clin Exp Invest 2013; 4:562-567
  10. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes Mellitus. N Engl J Med 1993; 329:977-986
  11. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet 1998; 352:854-865
  12. Tarı Selçuk K, Sözmen MK, Ünal B. Balçova’da 30 yaş ve üzeri diyabetlilerde tedavi alma ve kan glukoz düzeyinin kontrol altına alınma durumu. Turk J Public Health 2015; 13:40-52
  13. Banegas JR, Lopez-Garcia E, Dallongeville J, Guallar E, Halcox JP, Borghi C et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J 2011; 32:2143-2152
  14. Choe HM, Townsend KA, Blount G, Lo CH, Sadowski L, Standiford C. Treatment and control of blood pressure in patients with diabetes Melli